<unk> in the context of chemotherapy is an acronym that means a chemotherapy regimen most often used as an induction regimen in acute myelogenous leukemia, usually for those who are refractory to the standard "7+3" induction regimen or who has relapsed. But this regimen also can be used as primary, first-line induction therapy. The<unk> regimen consists of: # (D)aunorubicin - an anthracycline antibiotic that is able to intercalate DNA, thus disrupting cell division and preventing mitosis; # (A)ra-C (cytarabine) - an antimetabolite; # (T)hioguanine - another antimetabolite.
DAT 
FODMAP
LOINC
DCAP-BTLS
KHAT
NLM
ATNAA
SCALPEL